Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of antihistamine premedication and infusion prolongation to prevent oxaliplatin hypersensitivity reactions
TCTR20210506001Phase 2Completed
- Sponsor
- Chulalongkorn University
- Start
- Jul 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in cancer, sponsored by Chulalongkorn University. Started Jul 2020; status: completed.
02
Drugs
oxaliplatin
03
Conditions
cancer
Beyond the preview
Go deeper on TCTR20210506001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210506001.